v3.26.3
Condensed Balance Sheets - USD ($)
Jul. 31, 2026
Jan. 31, 2026
Current Assets    
Cash $ 545,960 $ 100,000
Prepaid expenses 86,076
Total Current Assets 632,036 100,000
Deferred offering costs 232,134
Investments held in Trust Account 106,372,992
Total Assets 107,005,028 332,134
Current Liabilities    
Accounts payable and accrued expenses 18,854 3,000
Total Current Liabilities 53,731 361,921
Deferred underwriting fee payable 3,675,000
Total Liabilities 3,728,731 361,921
Commitments and Contingencies – see Note 6  
Ordinary shares, $0.0001 par value, 500,000,000 shares authorized, 10,500,000 shares at redemption value of $10.13 per share as of July 31, 2026 and 0 shares subject to possible redemption as of January 31, 2026 106,372,992
Shareholders’ Deficit    
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 3,001,250(1)(2) shares and 2,875,000(1) shares issued and outstanding as of July 31, 2026 and January 31, 2026, respectively (excluding 10,500,000 and 0 shares subject to possible redemption as of July 31, 2026 and January 31, 2026, respectively) 300 287
Additional paid-in capital 24,713
Accumulated deficit (3,096,995) (54,787)
Total Shareholders’ Deficit (3,096,695) (29,787)
Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit 107,005,028 332,134
Related Party [Member]    
Current Liabilities    
Due to related party 34,877 58,921
Promissory note – related party $ 300,000